Project Description

£399 + £30 phlebotomy fee

Our Female Cancer Screening Test offer a detailed analysis of key cancer markers tailored for women’s health. This comprehensive panel includes tests for Ovarian Cancer (CA-125), Breast Cancer (CA 15-3), and Gastrointestinal Cancer (CA 19-9), alongside Universal Cancer Markers like Carcinoembryonic Antigen (CEA) and Alpha-fetoprotein (AFP). These tests are crucial for early detection, monitoring treatment response, and tracking disease progression in various cancers. It’s important to note that elevated marker levels should be evaluated in conjunction with other diagnostic methods and under professional medical guidance. This testing suite is an essential tool for women taking proactive steps in their healthcare journey.

  1. Ovarian Cancer Marker: Cancer Antigen-125 (CA-125) for early detection and monitoring of ovarian cancer.
  2. Breast Cancer Marker: Cancer Antigen 15-3 (CA 15-3) to identify and monitor breast cancer.
  3. Gastrointestinal Cancer Marker: Cancer Antigen 19-9 (CA 19-9) for detection of cancers in the gastrointestinal tract.
  4. Universal Cancer Markers: Carcinoembryonic Antigen (CEA) and Alpha-fetoprotein (AFP) to identify a broad range of potential cancers.

  1. Hereditary Concerns: Women with a family history of cancer.
  2. Post-Treatment Monitoring: Individuals tracking cancer markers for signs of recurrence.
  3. Preventive Screening: Those seeking comprehensive cancer screening specific to women’s health.
  4. Symptom Investigation: Women experiencing symptoms that necessitate a deeper look into potential cancer indicators.

The Female Cancer Screening Tests, including markers like CA-125, CA 15-3, CA 19-9, CEA, and AFP, are generally recommended in specific circumstances:

  1. Ongoing Monitoring for Known Cancer Patients: If you have a history of cancer, particularly ovarian, breast, or gastrointestinal cancers, these tests can be used regularly to monitor the effectiveness of treatment and check for any signs of recurrence.
  2. High-Risk Individuals: Women with a family history of cancer or known genetic predispositions (like BRCA mutations for breast cancer) may benefit from these tests as part of their regular health check-ups.
  3. Symptomatic Individuals: If you are experiencing symptoms suggestive of cancer (such as unexplained weight loss, persistent bloating, unusual lumps, or changes in bowel habits), these tests can be part of the diagnostic process.
  4. Postmenopausal Women: Particularly for the CA-125 test, which is used for ovarian cancer screening, postmenopausal women might be recommended this test if they show specific symptoms or are at a high risk.
  5. As Recommended by a Healthcare Professional: It’s crucial to follow the advice of your doctor. These tests are not typically used for general screening in the average-risk population but may be recommended based on your personal health history and risk factors.